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FREE RADICALS: REACTIVE OXYGEN AND NITROGEN SPECIES
The pathogenic role of oxygen free radicals in diseased states was first recognized by Harman (54, 55) , who hypothesized that they were generated in vivo where they played a role in cell injury, cancer, and the process of aging. Subsequently, free radicals have been shown not only to be a cause of cell damage but are also involved in a variety of mechanisms that ensure cellular physiological equilibrium, such as regulation of vascular tone, sensing of oxygen tension, and signal transduction (35) . Biologically active free radicals are of two kinds, reactive oxygen species (ROS) and reactive nitrogen species (RNS), and their generation, chemical reactions, and in vivo effects are closely interrelated.
The major ROS are superoxide (O 2 Ϫ ⅐), hydrogen peroxide (H 2 O 2 ), and hydroxyl radical (⅐OH Ϫ ). These ROS are generated as intermediate products in the reduction of oxygen to water (redox reactions).
One of the most important biological mechanisms of ROS generation results from the generation of O 2 Ϫ ⅐ from O 2 by the enzyme NAD(P)H oxidase (48) . The best characterized NAD(P)H oxidase is that present in neutrophils where it has a critical role in the "oxidative burst" that is the first line of defense against bacteria. NADPH oxidase isoforms have also been identified in vascular smooth muscle cells (47, 108) , fibroblasts (69) , endothelial cells (68) , and mesangial cells (67) . Hydrogen peroxide is produced from O 2 Ϫ ⅐ by the enzyme superoxide dismutase and in the presence of iron-containing molecules, H 2 O 2 is reduced to ⅐OH. The hydroxyl radical is highly reactive and hence is short-lived, with its toxicity exerted locally.
RNS, such as nitrosonium cation (NO ϩ ), nitroxyl anion (NO Ϫ ), and peroxynitrate (ONOO Ϫ ) represent the second major type of free radicals. Many of these are generated by reaction of ROS with nitric oxide (NO) or NO-related products. NO generated by endothelial cells has a critical role in mediating endothelial cell viability and vascular smooth muscle vasodilation in a reaction of low-NO flux and very fast kinetics (71) . Interestingly, the reaction of oxidants with NO may scavenge O 2 Ϫ ⅐ and H 2 O 2 and hence provide some cellular protection by preventing ROS-mediated lipid peroxidation of cell membranes (62, 133) , a benefit that is offset by the generation of RNS that act by themselves to impose additional oxidative stress on the cell (Fig. 1) .
Under normal circumstances, the host is protected from the toxic effect of ROS and RNS by extra-and intracellular antioxidants and oxygen radical scavengers; however, when these defense systems are overwhelmed, the cell is placed under "oxidative stress" and may be injured, activated, or even die.
OXIDATIVE STRESS AND HYPERTENSION
Oxidative stress has been documented in both experimental and human hypertension (120, 150) . A number of investigations have shown that hypertension results from stimulating systemic ROS generation (85, 111, 143, 145, 146) , and a variety of antioxidant treatments reduce blood pressure in genetic and experimentally induced models of hypertension (23, 26, 36, 40, 77, 78, 102, 104, 127, 128, 144, 146, 147, 152) .
Increased ROS not only have a critical role in the initiation of hypertension but they may be generated by the hypertension itself, suggesting a vicious cycle (151) . Originally, it was assumed that elevation of the blood pressure per se does not induce oxidative stress in the vascular endothelium because norepinephrine-induced hypertension does not increase superoxide generation (81); however, this assumption was challenged by the studies of Barton et al. (8) , who showed that in experimental aortic coarctation, the organs in the hypertensive upper body had evidence of oxidative stress, whereas the organs in the lower normotensive body did not. Because the findings could not be attributed to hormonal or humoral factors, they were considered to be due to differences in baromechanical stress.
Stimulation of NAD(P)H oxidase is the primary source of oxidants in the systemic arterial vessels in ANG II-induced hypertension, DOCA-salt hypertension, renovascular hypertension, chronic renal insufficiency, and in the spontaneously hypertensive rat (SHR) (108, 120, 143, 154, 155) . In humans, NAD(P)H oxidase is the source of basal O 2 Ϫ ⅐ production in the vascular smooth muscle cells (12) , and it is increased in patients with essential hypertension (141) .
Prohypertensive Mechanisms of Oxidative Stress
The mechanisms whereby systemic oxidative stress plays a role in the pathogenesis of hypertension involve both hemodynamic (vasoconstrictive) and structural (vascular remodeling) mechanisms. ROS can activate signaling cascades in vascular smooth muscle cells (6, 28, 34, 52, 79) that induce remodeling in resistance arteries, resulting in increased wall rigidity and narrowing of the lumen. These changes have been assumed to cause or maintain hypertension. However, the real contribution of these modifications to the elevation of the blood pressure has been questioned by the lack of correlation between vascular remodeling and blood pressure (56, 97) and by recent observations in one-kidney one-clip renovascular hypertension which have demonstrated that removal of the clip normalized the blood pressure while the structural alterations in peripheral arteries remained unchanged (80) .
A separate issue is the role of hypertrophic modifications in the afferent arteriole of the glomerulus. ROS-induced vascular remodeling in these arterioles may impair the vasomotor responses that protect glomeruli from systemic hypertension and induce distal tubulointerstitial ischemia. Both of these effects likely have a pathogenetic role in hypertension (65) .
As indicated in Fig. 1 , vasoconstriction of both systemic and intrarenal vessels may also result from both direct and indirect actions of ROS (125) . ROS can inactivate endothelial NO, resulting in impaired vasodilatation (24, 82, 122, 152) , and recent studies in humans with renovascular hypertension have validated this postulate (61) . In addition, there are direct effects of ROS on vascular tone. Whereas ROS can induce vasoconstriction or vasodilation, depending on the amount produced and the vascular bed (35) , the more common response to O 2 Ϫ ⅐ is vasoconstriction (125) . Other mechanisms of ROS-induced vasoconstriction include oxidation of arachidonic acid with formation of vasoconstrictive eicosanoids (such as prostaglandin F 2␣ ) (138) and inhibition of the synthesis of vasodilatory PGI 2 (160) . Furthermore, O 2 Ϫ ⅐ induces increments in intracellular calcium in smooth muscle and endothelial cells (84) , thereby mediating the actions of other vasoconstrictors such as ANG II, thromboxane (TXA 2 ), endothelin-1 (ET-1), and norepinephrine (125) .
In addition to systemic effects of ROS, recent evidence suggests that oxidant stress within the kidney plays a central role in the pathophysiology of sodium retention because it results in tubulointerstitial accumulation of ANG II-positive cells (114, 116, 117) . The sodium-retaining mechanisms resulting from intrarenal ANG II activity will be discussed in the next section. The prohypertensive role of intrarenal ROS is suggested by the strong correlation between renal superoxidepositive cells and the severity of hypertension in the SHR (Fig. 2) .
Tubulointerstitial Inflammation and Hypertension
Evidence for an immune mechanism in the pathogenesis of hypertension was first advanced by Svendson (135) , who observed, more than a quarter century ago, that the late saltdependent phase of the DOCA-salt model of hypertension required an intact thymus with the infiltration in the kidney of perivascular lymphocytes displaying "delayed-type immune reactivity." These observations were largely ignored despite the findings that cyclophosphamide therapy (9), anti-thymocyte serum (11) , neonatal thymectomy (73) , and thymic implants from normotensive donors (5a) could ameliorate hypertension in various models in rats. These early findings were interpreted by the investigators as evidence that the hypertension resulted from autoimmune vasculitis. In fact, the immune dysfunction observed in SHR (reviewed in Refs. 38 and 72) was considered to be an adaptive defense mechanism against otherwise life-threatening hypertension (11) . In contrast, recent work has provided evidence that immune cells accumulating in the kidney may be responsible for mediating sodium retention and, thereby, for the development of hypertension. First, tubulointerstitial infiltration of lymphocytes and macrophages appears to be universally present in experimental models of salt-sensitive hypertension. These include DOCA-salt hypertension, post-ANG II infusion salt-sensitive hypertension, postcathecholamine infusion salt-sensitive hypertension, hyperuricemia-induced salt sensitivity, hypertension after chronic NO synthesis inhibition, hypertension associated with protein overload proteinuria, hypokalemic nephropathy-associated salt sensitivity, two-kidney one-clip hypertension (persisting after clip removal), aging nephropathy, and cyclosporine nephropathy, as well as genetic models of hypertension such as the SHR, the stroke-prone SHR, and the double transgenic rat harboring the human renin and angiotensinogen genes (reviewed in Ref. 115) . Second, several investigations have demonstrated a direct correlation between the number of infiltrating cells and the severity of hypertension (3, 116, 117 ). An example of this correlation is shown in Fig. 3 .
Finally, and most importantly, a number of studies have shown that treatment strategies that result in a reduction in the renal inflammatory cell infiltrate also prevent the development of salt-sensitive hypertension (4, 107, 114) or improve established hypertension in genetically prone strains of hypertensive rats (88, 94, 95, 99, 116, 117) . These studies are summarized in Table 1 . While these studies strongly suggest that the immune infiltrate is mediating the salt sensitivity, a caveat is that mycophenolate mofetil (MMF) and the other therapies may also be affecting resident cell populations (reviewed in Ref. 156) , which may also have a contributory role in the prevention of salt-driven hypertension in these experimental models.
Prohypertensive Effects of Tubulointerstitial Inflammation
The mechanism(s) by which the immune infiltrate contributes to the pathogenesis of hypertension is incompletely defined but may relate to the sodium-retaining effects of intrarenal ANG II activity induced by the accumulation of immune cells. As shown by double-immunostaining studies, ANG II is expressed by infiltrating T cells and macrophages in experimental models of hypertension (4, 107, 116) . Both of these cells are known to express angiotensin-converting enzyme (31) , and macrophages are capable of synthesizing ANG II (148) . Interstitial accumulation of ANG II-positive cells has also been postulated as the reason for primary sodium retention in patients with the nephrotic syndrome (112) .
As shown in Fig. 4 , well-known renal effects of ANG II include a decreased glomerular filtration rate (GFR; which will reduce the filtered sodium load), an increase in tubular sodium reabsorption, and an impairment of pressure-natriuresis. Franco et al. (42) studied the glomerular hemodynamic findings in the model of salt-sensitive hypertension induced by ANG II infusion and the changes associated with MMF treatment. ANG II infusion, as expected, caused an increase in afferent and efferent arteriolar resistances with a decrease in single-nephron GFR and filtration coeffecient K f . In the weeks that follow ANG II infusion, in which a high-salt diet induces hypertension, the hemodynamic alterations remained essentially unchanged, consistent with a persistent intrarenal vasoconstriction. Treatment with MMF did not change the glomerular vasoconstriction induced during the exogenous ANG II administration but prevented glomerular vasoconstriction in the subsequent salt-sensitive period (42) . These studies suggested a role for ANG II-like intrarenal activity that was related to the interstitial immune infiltrate. Investigations from Nishiyama at al. (101) have convincingly shown increased endogenous production of intrarenal ANG II in the ANG II infusion model and that interstitial ANG II functions as a separate compartment that is not modified by the systemic hemodynamic changes known to modulate plasma ANG II concentrations (100, 101 ). An example of ANG II-positive tubular cells and infiltrating cells is shown in Fig. 5 .
In addition to the sodium-retaining effects, intrarenal ANG II activity has other potential consequences, including the activation of signaling cascades and transcription factors that could further increase interstitial inflammation (123) and stimulation of NAD(P)H oxidase-mediated superoxide production. These changes likely contribute to the maintenance of the low-grade renal injury and peritubular capillary loss (65) that participate in the pathophysiology of sodium balance in hypertension (51, 53) .
Interrelationship Between Renal Oxidative Stress and Interstitial Inflammation
Interstitial accumulation of lymphocytes and macrophages in the kidney is a consequence of the complex and intimate relationship between inflammatory reactivity and oxidative stress that stimulates mechanisms of cell death and cell survival. As an example of this relationship, Fig. 6 shows the close correlation between the renal infiltration of macrophages and oxidative stress in the SHR. HBP, hypertension; SSHBP, salt-sensitive HBP; dTGF, double transgenic rats harboring both human renin and angiotensinogen genes; AP-1, activator protein 1; DEXA, dexamethasone; MHC II, major histocompatibility complex II; PDTC, pyrolidine dithiocarbamate; NF-B, nuclear factor-B; L, lymphocytes; M, macrophages; NOS, nitric oxide synthesis; MMF, mycophenolate mofetil; L-NAME, N -nitro-L-arginine-methyl ester; SHR, spontaneously hypertensive rat. The reduction of oxidative stress shown represents a reduction of urinary or renal malondialdehyde content, plasma H2O2 concentration, renal nitrotyrosine abundance, or the number of superoxide-positive cells. ROS may induce a wide range of cellular responses, ranging from proliferation to cell apoptosis (21, 50, 63) . Certain transcription factors, such as NF-B and activator protein-1, are redox sensitive and will be activated by oxidants (35) . MAP kinases, such as ERK 1 and 2 are activated by O 2 Ϫ ⅐ in vascular smooth muscle cells (6) , and JNK and p38 are activated by H 2 O 2 (28, 29) .
The different pathways involved in signal transduction stimulated by oxidative stress are highly interconnected and modulate each other's activities so that the outcome depends on the dose of oxidant stress and the physiological context in which they are examined. Figure 7 indicates some of the biological pathways that interrelate oxidative stress and inflammatory reactivity that have already been found to be stimulated in models of salt-sensitive hypertension.
In general, low doses of ROS induce mitogenic responses, intermediate doses induce growth arrest, and severe oxidant stress causes apoptosis or necrosis (86) . Mitogenic, predominantly cell survival responses include activation of the ERK pathway, phosphatidylinositol 3-kinase/Akt (protein kinase B), and phospholipase C-␥1 signaling (51, 153, 158) . In addition, oxidative stress induces activation of NF-B (17, 83, 129) , which is a rapid-response transcription factor of proinflammatory genes. The activation of NF-B is the result of peroxideinduced phosphorylation of the inhibitory binding protein IB (130, 157) . NF-B mediates the synthesis of a variety of cytokines and, in addition, promotes leukocyte infiltration because it increases the expression of adhesion molecules E-selectin, VCAM-1, and ICAM-1 (26, 91, 137) . As a result of these effects, oxidative stress is capable of inducing nonspecific inflammation, which would be maintained as long as oxidant stress is sustained (Fig. 7) . In models of salt-sensitive hypertension, interstitial inflammation is, in fact, associated with increased apoptosis and activation of NF-B (Fig. 8A ) (106) . Furthermore, inhibition of NF-B reduces the interstitial accumulation of inflammatory cells and lowers the blood pressure in hypertensive rat strains (88, 94) .
An additional mechanism for ROS-mediated inflammation may be the expression of heat shock proteins (HSPs), a wellpreserved response of living organisms to stressful situations such as heat, ATP depletion, and oxidants. HSPs act as chaperones that guide the assembly, folding, and location of various proteins in cells. HSPs are grouped in six families classified according to their molecular mass (HSP 100, 90, 70, 60, 40, and smaller HSPs). ROS is a well-known inducer of HSPs, and prior treatment with antioxidants inhibits their expression (46) . In turn, HSPs protect proteins against oxidative damage by decreasing intracellular levels of ROS by maintaining glutathione in a reduced state (5, 7), suppressing apoptotic pathways, such as the JNK pathway (103) , and inhibiting cytochrome c release and caspase activation (22, 32) . However, HSPs' effects on cell survival are complex and at times seemingly contradictory. If inflammation follows the stimulation of HSPs, they exert a protective effect; in contrast, when inflammation precedes the induction of HSPs, the resulting effect is frequently cell death by apoptosis, a phenomenon called the "heat shock paradox," in which the participation of NF-B activity has been postulated (33) .
As shown in Fig. 7 , HSPs are part of the vicious cycle that results in renal interstitial inflammation in circumstances of sustained ROS production. HSPs induce the production of proinflammatory cytokines and overexpression of adhesion molecules E-selectin, ICAM-1, and VCAM-1 (45, 76, 105) and, therefore, facilitate the accumulation of immune cells characteristic of experimental models of salt-sensitive hypertension.
The distribution and function of HSPs in the kidney have recently been reviewed (10) , and several studies have demonstrated that experimental manipulations known to be associated with the subsequent development of salt-sensitive hypertension stimulate expression of HSPs. Infusion of ANG II induces renal overexpression of HSP70, HSP60, HSP25, HSP32, and heme oxygenase (HO-1) (1, 19, 64) that is mediated by ANG II type 1 receptor activation (114) . As demonstrated in Fig. 8B , overexpression of HSP70 is also induced by NO synthase (NOS) inhibition. In both of these models, increased oxidative stress has been postulated as the likely stimulus for HSP production. Fig. 6 . Relationship (r ϭ 0.76, P Ͻ 0.001) between the tubulointerstitial infiltration of macrophages (ED1-positive cells) and the intensity of oxidative stress (superoxide-positive cells). Data were obtained from kidneys harvested from rats that were given 2 wk of subcutaneous infusion of ANG II (ANG II group) or 3 wk of oral administration of N -nitro-L-arginine methyl ester (L-NAME) to inhibit NO synthase (L-NAME group). Additional groups of rats received mycophenolate mofetil during ANG II infusion (ANG II ϩ MMF group) and during L-NAME administration (L-NAME ϩ MMF). Data are from studies described in Refs. 19 and 106. Last, interstitial inflammation and oxidative stress may participate jointly in the development and maintenance of hypertension by the reduction of the number of nephron units, which thereby limits sodium filtration (20) . It is well recognized that the severity of tubulointerstitial damage correlates with renal functional deterioration (15, 16, 98) , and immune cell infiltration is a final common pathway to end-stage renal disease (113) . The reduction in tubulointerstitial inflammation by a variety of treatment modalities prevents or retards the development of end-stage renal disease (43, 44, 109, 119) . The link among interstitial immune infiltration and oxidative stress and hypertension is obvious in these circumstances. In addition, recent work links inflammatory reactivity and oxidative stress in the tubulointerstitium with the development of glomerular arteriolopathy, a process that may lead to impaired autoregulatory responses, resulting in increased transmission of systemic pressures to the glomeruli where they may predispose the animal to the development of glomerulosclerosis (14, 139) .
DOES T CELL INFILTRATION IN THE RENAL INTERSTITIUM REFLECT AN AUTOIMMUNE REACTION?
The coexistence of HSPs, increased apoptosis, and oxidative stress brings up the possibility that autoimmunity reactivity could be involved in the maintenance of low-grade, selfsustained interstitial inflammation and thereby participate in the pathogenesis of salt-sensitive hypertension. While evidence in favor of this possibility is lacking at the present time, certain aspects make this speculation worth considering. Models of salt-sensitive hypertension require an induction phase of 2-to 3-wk duration (4, 107, 114) , and this induction phase is characterized by cellular injury that could result in the expression of neoantigens or altered self-antigens that are viewed as "foreign" by the host. For example, tubular epithelial cell transdifferentiation, as demonstrated by vimentin neoexpression, is a feature of some of these models (19, 34) . This finding is not unexpected because activated macrophages (92) and ANG II (75) can induce vimentin expression. This raises the possibility that immune reactivity to vimentin or related proteins may be involved in the development of autoimmunity, as has been shown in rejection episodes of human heart transplantation and in autoimmune myocarditis (70, 124) .
HSPs may also have a direct role in the development of autoimmunity. HSPs have a role in antigen presentation (159) and may act as activators of innate immunity (100). HSPs themselves can be the cause of autoimmune disease. For example, Weiss et al. (149) showed that T cells reactive against HSPs can induce interstitial nephritis. In addition, HSPs are known to bind peptides in damaged tissue to form HSP-peptide complexes with strong immunogenicity (27, 142) .
Apoptosis is another potential cause of antigen-specific inflammatory reactivity (Fig. 7) . While prompt phagocytosis of apoptotic cells is not associated with inflammation, apoptotic cells have intracellular antigens translocated to the cell surface, and recent evidence indicates that an excess load or abnormal processing of apoptotic cells can generate autoantibody formation. Hypergammaglobulinemia, anti-DNA, and anti-cardiolipin antibodies can be generated by exposure to syngeneic apoptotic cells (30, 89, 90) . Of note, apoptosis is markedly increased in the kidney in models of experimental hypertension such as ANG II infusion and NOS synthesis inhibition (106) . An example of apoptotic tubulointerstitial cells induced by ANG II is shown in Fig. 8C .
Another influence that could favor the development of local autoimmunity is oxidative stress itself. Functional activation of lymphocytes is stimulated by ROS as a shift in the intracellular redox state can amplify the responses after relatively weak receptor stimulation (59) . An example of this amplified response is the generation of cytotoxic T cells after immunization in mice with cells expressing foreign minor histocompatibility antigens (121) .
CLINICAL CONSIDERATIONS
The experimental evidence supporting the role of oxidative stress and infiltration of immune cells in the renal interstitium in the pathogenesis of arterial hypertension is compelling. In contrast, clinical studies have failed to yield conclusive results. Some studies have shown that the administration of antioxidant vitamins reduces blood pressure (18, 36, 41, 93) , which is consistent with earlier studies that showed that local infusion of ascorbic acid improves endothelial-dependent vasodilatation (136) and with reports of an inverse correlation between serum carotene and vitamin C and blood pressure (25) . In contrast, as reviewed recently (140), other large series failed to show any blood pressure-lowering effect (74) , and studies designed to evaluate the modification of cardiovascular risk by antioxidant therapy did not report significant effects on blood pressure (49, 57, 58, 132) .
There are several aspects worth considering with regard to the lack of uniformity in the results of the clinical trials that examined the effects of antioxidant therapy in hypertension. These aspects may also serve as potential guidelines in future clinical studies. First, there is the problem of defining the severity of systemic oxidative stress and the intensity of the antioxidant treatment that would be required. Most studies determine levels of antioxidant vitamins but not the baseline levels of ROS or the changes in ROS levels with treatment which would indicate that a therapeutic goal has been achieved. It may be important to adjust the dose of antioxidant therapy based on the hydrogen peroxide or malondialdehyde plasma levels. While establishing target levels is relatively easy for drug dosages in acute studies, such as when intravenous iron or erythropoietin is given (60) , this may be considerably more difficult in the long-term follow-up of patients given the variability introduced by diet, hemoglobin levels, and physical activity, among others. Second, a separate assessment of systemic vs. intrarenal oxidative stress may be useful. High urinary malondialdehyde excretion may reflect intrarenal ROS with active interstitial inflammation in the kidney (118, 119) and may suggest a potential benefit of antioxidants and, indeed, sodium restriction. Third, there is the choice of antioxidant treatment for a specific patient. It is possible that patients with obesity, hyperinsulinemia, and hypertension may benefit from dietary modifications and exercise that induce reduction in oxidative stress with improvement in the metabolic profile and blood pressure (110) , whereas patients with acute increments of oxidative stress, such as from a hypertensive crisis, may require an antioxidant that acts rapidly after oral administration, such as melatonin (60) , in addition to standard emergency antihypertension treatment.
Finally, while antioxidants may block some of the inflammatory response, it is possible that the concomitant use of other anti-inflammatory agents may help to prevent the infiltration of ANG II-and oxidant-producing cells. While nonsteroidal antiinflammatory agents would be contraindicated because of the potential deterioration of renal function, angiotensin-converting enzyme inhibitors and statins have considerable anti-inflammatory actions (131, 134) . Experimental studies also suggest the possibility of using uric acid-lowering drugs as a means of reducing renal microvascular and tubulointerstitial inflammation and blood pressure (66, 87) .
Future clinical studies evaluating treatment strategies for salt-sensitive hypertension should consider focusing not only on drugs that lower blood pressure but additionally on the control of oxidative stress, intrarenal ANG II activity, and interstitial inflammation in the kidney. The combined approach may be more effective because these four elements support one another, all for one and one for all, like Alexander Dumas' three musketeers, who, after all, also ended up numbering four. Studies directed to gain insight into the intimate relationship that binds these elements may lead to a better understanding of the pathogenesis of essential hypertension and its treatment. 
